Our B7H6 expression analyses revealed that in addition to the established leukemia, melanoma, and epithelial tumor cell lines tested, at least 40% of all primary AML blasts expressed B7H6 at the cell surface. The gene discussed is NCR3LG1; the disease is acute myeloid leukemia.